Tyler Golato
Co-Initiator （ VitaDAO · Partner （ Triplicate · Co-Founder （ Molecule · Co-Initiator （ BIO Protocol
Tyler GolatoはTriplicateのパートナーであり、医薬品開発のためのオープンソースプロトコルであるMoleculeの共同創業者です。以前は、Dr. David M. Wilson IIIとDr. Vilhelm Bohrの指導の下、National Institute of Aging Research (NIH/NIA/IRP)で、特に老化の文脈における内因性DNA損傷の修復に焦点を当てて研究していました。さらに、TylerはVitaDAOとbio.xyzを共同創業しました。DeSciで働く前、Tylerは生化学者、分子生物学者、そして生物老年学者として優れた初期のキャリアを築いていました。
現在の役職
投資
ニュース言及
May in the Biosphere 🌐 - PeptAI Ignition Sale: 32x+ oversubscribed, 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims now live in the Bio app. Next: first on-chain wet-lab attestation via Molecule Labs in Q2. - BIO on Robinhood: $BIO is now tradable on @RobinhoodApp, bringing
The chemical universe is too massive for brute-force computing. "It would take over 170 years to brute force this data set by running inference on every single possible molecule." @metanova_labs #SN68 "Nova blueprint" incentivizes global miners to design and open-source their algorithmic shortcut
hot take: a single water molecule isn't wet. but two are.
This AI Reads Your Chemistry Instructions and Finds the Best Way to Build You a Molecule
For a decade, AI, Web3, and Bio have scaled as parallel frontiers, but that era is ending.The defining companies of the
For a decade, AI, Blockchain, and Bio have scaled as parallel frontiers - but that era is ending.The defining companies
We're excited to announce The Convergence, YZi Labs' flagship conference of the year. On May 12 at the iconic Computer H
The scientist who would have studied your disease probably chose a different problem.
Most people describe biotech companies as a jump from discovery to application.
Prompt-to-DeFi Strategist Challenge: BNB Chain Edition